Open label treatment and survival continuation study of atamestane plus toremifene versus letrozole in advanced breast cancer

Trial Profile

Open label treatment and survival continuation study of atamestane plus toremifene versus letrozole in advanced breast cancer

Discontinued
Phase of Trial: Phase III

Latest Information Update: 07 Dec 2012

At a glance

  • Drugs Atamestane; Letrozole; Toremifene
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Sponsors Intarcia Therapeutics
  • Most Recent Events

    • 07 Sep 2007 Status change from in progress to discontinued.
    • 17 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top